Key team members here include: Ciera A
Product Attributes CAS # : 189691-06-3 Molecular Formula : C50H68N14O10 Sequence (AA) : Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH Molecular Weight : 1025.2 g/mol PubChem CID : 9941379 Half-Life : ~2 hours Synonyms : Bremelanotide, PT-141, BMT-141, Vyleesi Type : Synthetic research peptide (melanocortin receptor agonist) Research Focus : Sexual Health & Libido, Neurological & Cognitive Function Scientific References Bremelanotide for treatment of female hypoactive sexual desire Human RCT | Regulatory Efficacy and Safety of Bremelanotide for Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials Human RCT Bremelanotide: an overview of preclinical CNS effects on female sexual function Animal | In vitro The Melanocortin System and Its Role in Sexual Function Animal | In vitro Intranasal bremelanotide in men with erectile dysfunction Human RCT FDA Label: Vyleesi (bremelanotide) injection Regulatory Melanocortin receptor agonists and central regulation of sexual behavior Animal | In vitro Bremelanotide (PT-141): research summary, mechanism, and effects Observational | Human RCT Included In The Box Every product arrives in a premium, custom-designed PEPTIDE.Power box , engineered for convenience, hygiene, and safe storage in your refrigerator
The mechanism centers on tissue repair signaling and gastric motility regulation
A 10 mg/mL concentration is sometimes used for maintenance phase
Dinner: Wild salmon with roasted vegetables and cooled potato salad
Future Directions for Prednisone Reducing Side Effects: Selective Glucocorticoid Receptor Agonists (SEGRAs): Researchers are developing newer types of glucocorticoids that aim to retain the anti-inflammatory benefits of prednisone while minimizing its side effects
